Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8

Inagaki, Katsuya, Fuess, Sally, Storm, Theresa A., Gibson, Gregory A., Mctiernan, Charles F., Kay, Mark A., Nakai, Hiroyuki·2006·Molecular Therapy
DOI 10.1016/j.ymthe.2006.03.014

Cited by (613)

Items 301–400 of 613

  1. Adeno‐associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling
    Prasad R. Konkalmatt, Feng Wang, Bryan A. Piras, Yaqin Xu, Daniel M. O’Connor, Ronald J. Beyers, Frederick H. Epstein, Brian Herb Annex, John A. Hossack, Brent A. French · 2012 · The Journal of Gene Medicine
  2. Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters
    Katrin Schaar, Anja Geisler, Milena Kraus, Sandra Pinkert, Markian Pryshliak, Jacqueline F. Spencer, Ann E. Tollefson, Baoling Ying, Jens Kurreck, William S.M. Wold et al. · 2017 · Molecular Therapy — Nucleic Acids
  3. Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice
    Maren Leifheit‐Nestler, Miriam Wagner, Beatrice Richter, Corinna Piepert, Fiona Eitner, Ineke Böckmann, Isabel Vogt, Andrea Grund, Susanne S. Hille, Ariana Foinquinos et al. · 2021 · Frontiers in Cell and Developmental Biology
  4. CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver
    Thorsten Kaltenbacher, Jessica Löprich, Roman Maresch, Julia Weber, Sebastian Müller, Rupert Oellinger, Nina Groß, Joscha Griger, Niklas de Andrade Krätzig, Petros Avramopoulos et al. · 2022 · Nature Protocols
  5. Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer.
    Bo Lei, Keqing Zhang, Yongping Yue, Arkasubhra Ghosh, Dongsheng Duan · 2009 · PubMed Central
  6. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy
    Mikako Ito, Yuka Ehara, Jin Li, Kosuke Inada, Kinji Ohno · 2016 · Human Gene Therapy
  7. Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy
    Haiqing Yi, Quan Zhang, Elizabeth Drake Brooks, Chunyu Yang, Beth L. Thurberg, Priya Sunil Kishnani, Baodong Sun · 2016 · Human Gene Therapy
  8. In Vivo Potency Assay for Adeno-Associated Virus–Based Gene Therapy Vectors Using AAVrh.10 as an Example
    Bishnu P. De, Alvin Chen, Christiana O. Salami, Benjamin G. Van de Graaf, Jonathan B. Rosenberg, Odelya E. Pagovich, Dolan Sondhi, Ronald G. Crystal, Stephen M. Kaminsky · 2018 · Human Gene Therapy Methods
  9. AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome
    Silveli Suzuki‐Hatano, Madhurima Saha, Meghan S. Soustek, Peter B. Kang, Barry J. Byrne, W. Todd Cade, Christina A. Pacak · 2019 · Molecular Therapy — Methods & Clinical Development
  10. Preclinical Development of New Therapy for Glycogen Storage Diseases
    Baodong Sun, Elizabeth Drake Brooks, Dwight D. Koeberl · 2015 · Current Gene Therapy
  11. Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin
    Qiao, Chunping, Dai, Yi, Nikolova, Viktoriya D., Jin, Quan, Li, Jianbin, Xiao, Bin, Li, Juan, Moy, Sheryl S., Xiao, Xiao · 2018 · Molecular Therapy - Methods & Clinical Development
  12. A calcium-sensitive promoter construct for gene therapy
    Elise Merlet, Larissa Lipskaia, Alexandre Marchand, Lahouaria Hadri, Nathalie Mougenot, Fabrice Atassi, Lifan Liang, Stéphane N. Hatem, Roger J. Hajjar, A-M Lompré · 2012 · Gene Therapy
  13. Prospects for gene transfer for clinical heart failure
    T. Tang, M. Gao, H. Hammond · 2012 · Gene Therapy
  14. Monobac System–A Single Baculovirus for the Production of rAAV
    Lionel Galibert, Aurélien Jacob, Adrien Savy, Yohann Dickx, Delphine Bonnin, Christophe Lecomte, Lise Rivollet, Peggy Sanatine, Marjorie Boutin Fontaine, Christine Le Bec et al. · 2021 · Microorganisms
  15. Prospects for gene replacement therapies in amyotrophic lateral sclerosis
    Ilaria Giovannelli, Adrian Higginbottom, Janine Kirby, Mimoun Azzouz, Pamela J. Shaw · 2022 · Nature Reviews Neurology
  16. Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders
    Cintia Elisabeth Gomez Limia, Megan Baird, Maura Schwartz, Smita Saxena, Kathrin Meyer, Nicolas Wein · 2022 · Journal of Personalized Medicine
  17. PEG-modulated column chromatography for purification of recombinant adeno-associated virus serotype 9
    Jing-Min Zhou, Xiao Jun Yang, John Fraser Wright, Katherine A. High, Linda B. Couto, Guang Qu · 2011 · Journal of Virological Methods
  18. Cardiac AAV9 Gene Delivery Strategies in Adult Canines: Assessment by Long-term Serial SPECT Imaging of Sodium Iodide Symporter Expression
    Gilles Moulay, Tomohito Ohtani, Ozgur Ogut, Adam J. Guenzel, Atta Behfar, Rosita Zakeri, Philip G. Haines, Jimmy R. Storlie, Lorna A. Bowen, Linh Pham et al. · 2015 · Molecular Therapy
  19. Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9
    Zheng Chai, Xintao Zhang, Amanda Lee Dobbins, Kelly Michelle Rigsbee, Bing Wang, Richard Jude Samulski, Chengwen Li · 2019 · Human Gene Therapy
  20. Disease Rescue and Increased Lifespan in a Model of Cardiomyopathy and Muscular Dystrophy by Combined AAV Treatments
    Carmen Vitiello, Stefania Faraso, Nicolina Cristina Sorrentino, Giovanni Di Salvo, Edoardo Nusco, Gerardo Nigro, Luisa Cutillo, Raffaele Calabrò, Alberto Auricchio, Vincenzo Nigro · 2009 · PLoS ONE
  21. Transparenchymal Renal Pelvis Injection of Recombinant Adeno-Associated Virus Serotype 9 Vectors Is a Practical Approach for Gene Delivery in the Kidney
    Xufeng Shen, Yuchen Xu, Zhengming Bai, Dongyue Ma, Qingsong Niu, Jialin Meng, Song Fan, Li Zhang, Zongyao Hao, Xiansheng Zhang et al. · 2018 · Human Gene Therapy Methods
  22. Progress in Bioengineering of Myotropic Adeno-Associated Viral Gene Therapy Vectors
    Jixin Liu, Teng Wei Koay, Olena Maiakovska, Margarita Zayas, Dirk Grimm · 2023 · Human Gene Therapy
  23. Exploiting Natural Diversity of AAV for the Design of Vectors with Novel Properties
    Guangping Gao, Zhong Li, Olivier Danos · 2011 · Methods in molecular biology
  24. Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
    A. Hotta · 2015 · Journal of Neuromuscular Diseases
  25. Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disorders
    Bhanu Munil Koppanati, Jianmin Li, Xiao Xiao, Paula R. Clemens · 2009 · Gene Therapy
  26. Creation of a cardiotropic adeno-associated virus: the story of viral directed evolution
    Lin Yang, Xiao Xiao · 2013 · Virology Journal
  27. Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back
    Laurine Buscara, David‐Alexandre Gross, Nathalie Danièle · 2020 · Journal of Personalized Medicine
  28. Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer’s Disease
    Alice Rossi, Luisa Galla, Chiara Gomiero, Lorena Zentilin, Mauro Giacca, Valentina Giorgio, Tito Calí, Tullio Pozzan, Elisa Greotti, Paola Pizzo · 2021 · Cells
  29. Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy
    Caroline Le Guiner, Xiao Xiao, Thibaut Larcher, Aude Lafoux, Corinne Huchet, Gilles Toumaniantz, Oumeya Adjali, Ignacio Anegón, Séverine Remy, Josh Grieger et al. · 2023 · Molecular Therapy — Methods & Clinical Development
  30. Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9
    David H. Stitelman, Tim R. Brazelton, Archana Bora, Jeremy Traas, Demetri J. Merianos, Maria P. Limberis, Marcus G. Davey, Alan W. Flake · 2014 · Molecular Therapy — Methods & Clinical Development
  31. Wnt11 Gene Therapy with Adeno-associated Virus 9 Improves Recovery from Myocardial Infarction by Modulating the Inflammatory Response
    Yoshihiro Morishita, Koichi Kobayashi, Ekaterina A. Klyachko, Kentaro Jujo, Kengo Maeda, Douglas W. Losordo, Toyoaki Murohara · 2016 · Scientific Reports
  32. Delta-Sarcoglycan Gene Therapy Halts Progression of Cardiac Dysfunction, Improves Respiratory Failure, and Prolongs Life in Myopathic Hamsters
    Masahiko Hoshijima, Takeharu Hayashi, Young E. Jeon, Zhenxing Fu, Yusu Gu, Nancy D. Dalton, Mark H. Ellisman, Xiao Xiao, Frank L. Powell, John Ross · 2010 · Circulation Heart Failure
  33. Intravenous Adeno-Associated Virus Serotype 8 Encoding Urocortin-2 Provides Sustained Augmentation of Left Ventricular Function in Mice
    Mei Hua Gao, Ning Lai, Atsushi Miyanohara, Jan Mirko Schilling, Jorge Suárez, Tong Tang, Tracy Guo, Ruoying Tang, Jay Parikh, Dimosthenis Giamouridis et al. · 2013 · Human Gene Therapy
  34. Gene and splicing therapies for neuromuscular diseases
    Aurélie Goyenvalle · 2015 · Frontiers in bioscience
  35. Follistatin N terminus differentially regulates muscle size and fat in vivo
    Hui Zheng, Chunping Qiao, Ruhang Tang, Jianbin Li, Karen Bulaklak, Zhenhua Huang, Chunxia Zhao, Yi Ling Dai, Juan Li, Xiao Xiao · 2017 · Experimental & Molecular Medicine
  36. Gene Therapy in Large Animal Models of Human Cardiovascular Genetic Disease
    Meg M. Sleeper, Lawrence T. Bish, Hugh Lee Sweeney · 2009 · ILAR Journal
  37. Cardiac Gene Therapy
    Antoine H. Chaanine, Jill Kalman, Roger J. Hajjar · 2010 · Seminars in Thoracic and Cardiovascular Surgery
  38. A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION
    Kei Adachi, Hiroyuki Nakai · 2010 · Gene Therapy and Regulation
  39. Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors
    Karen Nieto, Andrea Kern, Barbara Leuchs, Lutz Gissmann, Martin Müller, Jürgen A. Kleinschmidt · 2009 · Antiviral Therapy
  40. AAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice
    Markus B. Heckmann, Ralf Bauer, Andreas Jungmann, Lilli Winter, Kleopatra Rapti, Karl-Heinz Strucksberg, Christoph Stephan Clemen, Zhenlin Li, Rolf Schröder, Hugo Albert Katus et al. · 2016 · Gene Therapy
  41. Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors
    Warut Tulalamba, Jonas Weinmann, Quang Hong Pham, Jihad El Andari, Thierry VandenDriessche, Marinee Chuah, Dirk Grimm · 2019 · Gene Therapy
  42. Lysosomal-Associated Protein Transmembrane 5 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy
    Lu Gao, Sen Guo, Rui Long, Lili Xiao, Rui Yao, Xiaolin Zheng, Yanzhou Zhang, Xiaofang Wang · 2021 · Frontiers in Cardiovascular Medicine
  43. Single Tyrosine Mutation in AAV8 and AAV9 Capsids Is Insufficient to Enhance Gene Delivery to Skeletal Muscle and Heart
    Chunping Qiao, Zhenhua Yuan, Jianbin Li, Ruhang Tang, Juan Li, Xiao Xiao · 2012 · Human Gene Therapy Methods
  44. Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections
    Marc-André Robert, Nasha Nassoury, Parminder S. Chahal, Marie-Hélène Venne, Trina Racine, Xiangguo Qiu, Gary Kobinger, Amine Kamen, Rénald Gilbert, Bruno Gaillet · 2017 · Human Gene Therapy
  45. Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTag
    Khadija Cherif, Catherine Gérard, Joël Rousseau, Dominique L. Ouellet, Pierre Chapdelaine, Jacques P. Tremblay · 2018 · Molecular Therapy — Nucleic Acids
  46. Adeno-Associated Virus Vector Delivery to the Heart
    Lawrence T. Bish, Hugh Lee Sweeney, Oliver Josef Müller, Raffi Bekeredjian · 2011 · Methods in molecular biology
  47. Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth
    Chunping Qiao, Juan Li, Hui Zheng, Janet R. Bogan, Jianbin Li, Zhenhua Yuan, Cheng Zhang, Dan Bogan, Joe N. Kornegay, Xiao Xiao · 2008 · Human Gene Therapy
  48. AAV8-Mediated Long-Term Expression of Human LCAT Significantly Improves Lipid Profiles in hCETP;Ldlr+/− Mice
    Zhu Chen, Donald Chu, Jose M. Castro‐Perez, Weihua Ni, Aiwu Zhang, Mihajlo L. Krsmanovic, Dan Xie, Vinit Shah, Steven J. Stout, David G. McLaren et al. · 2011 · Journal of Cardiovascular Translational Research
  49. Intraperitoneal AAV9-shRNA inhibits target expression in neonatal skeletal and cardiac muscles
    Azat Mayra, Hiroyuki Tomimitsu, Takayuki Kubodera, Masaki Kobayashi, Wenying Piao, Fumiko Sunaga, Yukihiko Hirai, Takashi Shimada, Hidehiro Mizusawa, Takanori Yokota · 2011 · Biochemical and Biophysical Research Communications
  50. A novel gene delivery method transduces porcine pancreatic duct epithelial cells
    M A Griffin, Miguel Restrepo, Marwa Abu El Haija, Tanner J. Wallen, E Buchanan, Tatiana Rokhlina, Y H Chen, Paul B. McCray, Beverly L. Davidson, Abhay A. Divekar et al. · 2013 · Gene Therapy
  51. AAV9-Mediated Overexpression of TRPM4 Increases the Incidence of Stress-Induced Ventricular Arrhythmias in Mice
    Andy Pironet, Ninda Syam, Frone Vandewiele, Chris Van den Haute, Sara Kerselaers, Sílvia Pinto, Greetje Vande Velde, Rik Gijsbers, Rudi Vennekens · 2019 · Frontiers in Physiology
  52. Variability in Cardiac miRNA-122 Level Determines Therapeutic Potential of miRNA-Regulated AAV Vectors
    Izabela Kraszewska, Mateusz Tomczyk, Kalina Andrysiak, Monika Biniecka, Anja Geisler, Henry Fechner, Michał Oskar Zembala, Jacek Stępniewski, Józef Dulak, Agnieszka Jaźwa · 2020 · Molecular Therapy — Methods & Clinical Development
  53. A Single Intravenous AAV9 Injection Mediates Bilateral Gene Transfer to the Adult Mouse Retina
    Alexis‐Pierre Bemelmans, Sandra I. Duqué, Christel Rivière, Stéphanie Astord, Mélissa Desrosiers, Thibaut Marais, José‐Alain Sahel, Thomas Voït, Martine Barkats · 2013 · PLoS ONE
  54. New Vectors and Strategies for Cardiovascular Gene Therapy
    Agnieszka Jaźwa, Alicja Józkowicz, Józef Dulak · 2007 · Current Gene Therapy
  55. Population-wide gene disruption in the murine lung epithelium via AAV-mediated delivery of CRISPR-Cas9 components
    Honglin Chen, Steffen Durinck, Hetal Patel, Oded Foreman, Kathryn Mesh, Jeffrey Eastham, Roger H. Caothien, Robert J. Newman, Merone Roose‐Girma, Spyros Darmanis et al. · 2022 · Molecular Therapy — Methods & Clinical Development
  56. mRNA therapy for myocardial infarction: A review of targets and delivery vehicles
    Xinming Wang, Douglas H. Wu, Samuel E. Senyo · 2022 · Frontiers in Bioengineering and Biotechnology
  57. Advancements in Viral Gene Therapy for Gaucher Disease
    Akhil Kulkarni, Tiffany Chen, Ellen Sidransky, Tae‐Un Han · 2024 · Genes
  58. Intravenous administration of scAAV9-Hexb normalizes lifespan and prevents pathology in Sandhoff disease mice
    Natalia Niemir, Laura Rouvière, Aurore Besse, Marie Therese Vanier, Jasmin Dmytrus, Thibaut Marais, Stéphanie Astord, Jean-Philippe Puech, Ganna Panasyuk, Jonathan D. Cooper et al. · 2018 · Human Molecular Genetics
  59. A Hybrid Adenoviral Vector System Achieves Efficient Long-Term Gene Expression in the Liver via piggyBac Transposition
    Ryan P. Smith, Jesse D. Riordan, Charlotte R. Feddersen, Adam J. Dupuy · 2015 · Human Gene Therapy
  60. Recombinant adeno-associated virus vector for gene transfer to the transplanted rat heart
    Johannes M. Schirmer, Naoto Miyagi, Vinay P. Rao, Davide Ricci, Mark J. Federspiel, Robert M. Kotin, Stephen J. Russell, Christopher G.A. McGregor · 2007 · Transplant International
  61. Treatment of Heart Failure by Calcium Cycling Gene Therapy
    Larissa Lipskaia, Hung Q. Ly, Yoshiaki Kawase, Roger J. Hajjar, Anne‐Marie Lompré · 2007 · Future Cardiology
  62. Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations
    Lorenzo Ferri, Giuseppina Covello, Anna Caciotti, Renzo Guerrini, Michela A. Denti, Amelia Morrone · 2016 · Molecular Therapy — Nucleic Acids
  63. In Search of Adeno-Associated Virus Vectors With Enhanced Cardiac Tropism for Gene Therapy
    Natsuki Sasaki, Cindy Kok, Adrian Westhaus, Ian E. Alexander, Leszek Lisowski, Eddy Kizana · 2023 · Heart Lung and Circulation
  64. Adeno-Associated Virus Serotype-9 Mediated Retinal Outer Plexiform Layer Transduction is Mainly Through the Photoreceptors
    Bo Lei, Keqing Zhang, Yongping Yue, Arkasubhra Ghosh, Dongsheng Duan · 2009 · Advances in experimental medicine and biology
  65. Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models
    Michael P. Gannon, Mark S. Link · 2019 · Trends in Cardiovascular Medicine
  66. S151A δ-sarcoglycan mutation causes a mild phenotype of cardiomyopathy in mice
    Désirée Rutschow, Ralf Bauer, Caroline Goehringer, Raffi Bekeredjian, Stefanie Schinkel, Volker W. Straub, Michael Koenen, Dieter Weichenhan, Hugo Albert Katus, Oliver Josef Müller · 2013 · European Journal of Human Genetics
  67. Input‐specific regulation of hippocampal circuit maturation by non‐muscle myosin IIB
    Emin D. Ozkan, Massimiliano Aceti, Thomas K. Creson, Camilo Rojas, Christopher Hubbs, Megan N. McGuire, Priyanka Prakash Kakad, Courtney A. Miller, Gavin Rumbaugh · 2015 · Journal of Neurochemistry
  68. Selective tropism of the recombinant adeno‐associated virus 9 serotype for rat cardiac tissue
    Yanfei Qi, Xuan Liu, Hongwei Li, Vinayak Shenoy, Qiuhong Li, William W. Hauswirth, Colin Sumners, Michael J. Katovich · 2009 · The Journal of Gene Medicine
  69. Hepatic follistatin increases basal metabolic rate and attenuates diet-induced obesity during hepatic insulin resistance
    Rongya Tao, Oliver Stöhr, Caixia Wang, Wei Qiu, Kyle D. Copps, Morris F. White · 2023 · Molecular Metabolism
  70. Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice
    Jeong‐A Lim, Priya Sunil Kishnani, Baodong Sun · 2022 · JCI Insight
  71. Adeno-associated Virus Serotype 8 (AAV8) Delivery of Recombinant A20 to Skeletal Muscle Reduces Pathological Activation of Nuclear Factor (NF)-κB in Muscle of mdx Mice
    Rakshita A. Charan, Gabriela A. Niizawa, Hiroyuki Nakai, Paula R. Clemens · 2012 · Molecular Medicine
  72. The Non-coding Road Towards Cardiac Regeneration
    James E. Hudson, Enzo R. Porrello · 2013 · Journal of Cardiovascular Translational Research
  73. miRNAs got rhythm
    Terry S. Elton, Mickey M. Martin, Sarah E. Sansom, Andriy E. Belevych, Sándor Györke, Dmitry A. Terentyev · 2010 · Life Sciences
  74. Delivery of Recombinant Adeno-Associated Virus Vectors to Rat Diaphragm Muscle via Direct Intramuscular Injection
    Ashley J. Smuder, Darin J. Falk, Kurt J. Sollanek, W. Bradley Nelson, Scott K. Powers · 2013 · Human Gene Therapy Methods
  75. The Transcription Factor EB (TFEB) Sensitizes the Heart to Chronic Pressure Overload
    Sebastian Wundersitz, Cristina Pablo Tortola, Sibylle Schmidt, Ramon Oliveira Vidal, Melanie Kny, Alexander Hahn, Lukas Zanders, Hugo Albert Katus, Sascha Sauer, Christian Butter et al. · 2022 · International Journal of Molecular Sciences
  76. Gene therapy for heart failure: A novel treatment for the age old disease.
    N. Vora, Parth Patel, A. Gajjar, Parva Ladani, Ashwati Konat, Devanshi Bhanderi, Srikanth Gadam, Priyadarshi Prajjwal, Kamal Sharma, S. P. Arunachalam · 2023 · Disease-a-month : DM
  77. Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration
    Carolina Prezioso, Salvatore Iaconis, Gennaro Andolfi, Lorena Zentilin, Francescopaolo Iavarone, Ombretta Guardiola, Gabriella Minchiotti · 2015 · Frontiers in Cell and Developmental Biology
  78. Engineering a gene silencing viral construct that targets the cat hypothalamus to induce permanent sterility: An update
    Gregory A. Dissen, K Adachi, Alejandro Lomniczi, T. T. Chatkupt, Beverly L. Davidson, Hiroyuki Nakai, SR Ojeda · 2016 · Reproduction in Domestic Animals
  79. Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice
    Yihui Li, Hongdan Yan, Feng Wang, Shanying Huang, Yun Zhang, Zhihao Wang, Ming Zhong, Wei Zhang · 2017 · Biochemical and Biophysical Research Communications
  80. Gene Therapy in Skeletal Muscle Mediated by Adeno-Associated Virus Vectors
    Chunping Qiao, Taeyoung Koo, Juan Li, Xiao Xiao, J. George Dickson · 2011 · Methods in molecular biology
  81. Efficient cardiac gene transfer and early-onset expression of a synthetic adeno-associated viral vector, Anc80L65, after intramyocardial administration
    Michael G. Katz, Yoav Hadas, Rasheed A. Bailey, Shahood Fazal, Adam S. Vincek, Sophia J. Madjarova, Nataly Shtraizent, Luk H. Vandenberghe, Efrat Eliyahu · 2021 · Journal of Thoracic and Cardiovascular Surgery
  82. GADD45β stabilized by direct interaction with HSP72 ameliorates insulin resistance and lipid accumulation
    Yunxia Dong, Ningning Ma, Lei Fan, Luyang Yuan, Qian Wu, Likun Gong, Zhouteng Tao, Jing Chen, Jin Ren · 2021 · Pharmacological Research
  83. In vivo adenine base editing corrects newborn murine model of Hurler syndrome
    Jing Su, Xiu Jin, Kaiqin She, Yi Liu, Li Song, Qinyu Zhao, Jianlu Xiao, Ruiting Li, Hongxin Deng, Fang Lü et al. · 2023 · Molecular Biomedicine
  84. Recombinant Adeno-Associated Virus Type 8-Mediated Extensive Therapeutic Gene Delivery into Skeletal Muscle of α -Sarcoglycan-Deficient Mice
    Akiyo Nishiyama, Beryl Ampong, Sachiko Ohshima, Jin‐Hong Shin, Hiroyuki Nakai, Michihiro Imamura, Yuko Miyagoe‐Suzuki, Takashi Okada, Shin’ichi Takeda · 2008 · Human Gene Therapy
  85. Wnt11 gene therapy with adeno-associated virus 9 improves the survival of mice with myocarditis induced by coxsackievirus B3 through the suppression of the inflammatory reaction
    Yutaka Aoyama, Koichi Kobayashi, Yoshihiro Morishita, Kengo Maeda, Toyoaki Murohara · 2015 · Journal of Molecular and Cellular Cardiology
  86. Comparison of IL-10 and MCP-1-7ND gene transfer with AAV9 vectors for protection from murine autoimmune myocarditis
    Ziya Kaya, Christoph Leib, Stanislas Werfel, Stefan Göser, Renate Öttl, Barbara Leuchs, Gabriele Pfitzer, Hugo Albert Katus, Oliver Josef Müller · 2011 · Cardiovascular Research
  87. Oxidized LDL but not angiotensin II induces cardiomyocyte hypertrophic responses through the interaction between LOX-1 and AT1 receptors
    Lin Li, Ning Zhou, Le Kang, Qi Wang, Jian Wu, Xiaoyan Wang, Chunjie Yang, Guoping Zhang, Yunqin Chen, Hong Jiang et al. · 2021 · Journal of Molecular and Cellular Cardiology
  88. Recombinant AAV-mediated in vivo long-term expression and antitumour activity of an anti-ganglioside GM3(Neu5Gc) antibody
    Giulia Maria Piperno, Alejandro López‐Requena, Andrea Predonzani, Denise Dorvignit, Mayrel Labrada, Lorena Zentilin, Óscar R. Burrone, Michela Cesco-Gaspere · 2015 · Gene Therapy
  89. MG53 protects against Coxsackievirus B3-induced acute viral myocarditis in mice by inhibiting NLRP3 inflammasome-mediated pyroptosis via the NF-κB signaling pathway
    Yimin Xue, Tianjiao Song, Jun Ke, Shirong Lin, Jiuyun Zhang, Yimei Chen, Junyi Wang, Qiaolian Fan, Feng Chen · 2024 · Biochemical Pharmacology
  90. Effects of Mild Excitotoxic Stimulus on Mitochondria Ca2+ Handling in Hippocampal Cultures of a Mouse Model of Alzheimer’s Disease
    Giulia Rigotto, Lorena Zentilin, Tullio Pozzan, Emy Basso · 2021 · Cells
  91. LncGBP9 knockdown alleviates myocardial inflammation and apoptosis in mice with acute viral myocarditis via suppressing NF-κB signaling pathway
    Yimin Xue, Jiuyun Zhang, Jun Ke, Lijuan Zeng, Kun Cheng, Xu Han, Falu Chen, Feng Chen · 2022 · Inflammation Research
  92. Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity
    Cindy Kok, Lauren M. MacLean, Jett C. Ho, Leszek Lisowski, Eddy Kizana · 2021 · JACC CardioOncology
  93. Recombinant adeno-associated virus serotype 9 in a mouse model of atherosclerosis: Determination of the optimal expression time in vivo
    Qingjie Chen, Hui Zhai, Xiaomei Li, Yitong Ma, Bang‐Dang Chen, Fen Liu, Hongmei Lai, Jia Xie, Chunhui He, Junyi Luo et al. · 2017 · Molecular Medicine Reports
  94. Novel vectors forin vivogene delivery to vascular tissue
    Kathryn White, Stuart A. Nicklin, Andrew Howard Baker · 2007 · Expert Opinion on Biological Therapy
  95. Living myocardial slices for the study of nucleic acid-based therapies
    Raquel Núñez-Toldrà, A. Del Canizo, Ilaria Secco, Laura Nicastro, Mauro Giacca, Cesare M. Terracciano · 2023 · Frontiers in Bioengineering and Biotechnology
  96. Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases
    Abesh Bera, Dwaipayan Sen · 2017 · Heart Failure Reviews
  97. Local and systemic administration of AAV vectors with alphaherpesvirus latency-associated promoter 2 drives potent transgene expression in mouse liver, kidney, and skeletal muscle
    Carola J. Maturana, Angela Chan, Jessica L. Verpeut, Esteban A. Engel · 2023 · Journal of Virological Methods
  98. Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity
    Kei Adachi, Gregory A. Dissen, Alejandro Lomniczi, Qing Xie, Sergio R. Ojeda, Hiroyuki Nakai · 2020 · Scientific Reports
  99. Duchenne Cardiomyopathy Gene Therapy
    Jin‐Hong Shin, Brian Bostick, Deborah M. Fine, Yongping Yue, Dongsheng Duan · 2009 · Springer eBooks
  100. Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice
    Carsten Röger, Tanja Pozzuto, Robert Klopfleisch, Jens Kurreck, Sandra Pinkert, Henry Fechner · 2015 · Gene Therapy